Furthermore, the efficacy rate was higher in patients receiving CHM than in those receiving placebo (RR, 1.72 95% CI, 1.01 to 2.93 p = 0.04). The psoriasis area severity index (PASI) score of the CHM group was significantly lower than that of the placebo group (MD, −4.02 95% CI, −6.71 to −1.34 p = 0.003).
Results: Altogether, 1,215 patients participated in this study, including 711 in the experimental group and 504 in the control group.
#2019 review best chm reader for windows 10 pc software
The RevMan5.3 software was used to calculate risk ratios (RR) at 95% confidence intervals (CI) and conduct the meta-analysis.
High-quality randomized controlled trials that compared CHM with non-CHM interventions were included. Methods: Several databases were systematically searched including PubMed, Embase, Cochrane Central Register of Controlled Trials, China Network Knowledge Infrastructure, Chinese Scientific Journals Database, and Wan Fang Database. The purpose of this quantitative study was to show high-quality evidence of the efficacy and safety of CHM for the treatment of psoriasis to promote its clinical application.
0 kommentar(er)
